Search

Craig R Abolin

from Eastsound, WA
Age ~76
Get Report
Also known as:
Craig Dr Abolin, Craig J Abolin, Cynthia L Abolin, Craig R Abolind, Cynthia Abolin Ttees, Craig R
Phone and address:
513 Lookout Loop, Eastsound, WA 98245
(360) 376-2114
Related to:
Noah L Axelrod, 43Robert Axelrod, 76Cynthia Abolin, 73Keara Axelrod, 48
Connected to:
Daniel E Abolins, 59Melissa A Abolnik, 37Folasade J Aboloye, 62Raymond D Abolt, 51Fahd A Aboluhoom, 60Adetayo M Abon, 54Miguel Abonce, 51William J Abondolo, 54Xenia Abonia, 41Rose B Abono, 65

Craig Abolin Phones & Addresses

  • 513 Lookout Loop, Eastsound, WA 98245 (360) 376-2114 (360) 376-4355
  • Sioux Falls, SD
  • Boylston, MA
  • 1 Meadow Lark Ct, Randolph, NJ 07869 (973) 328-3988
  • Marlborough, MA
  • Warrenton, VA
  • Rockaway, NJ
  • Landing, NJ

Work

Company: Or-genix therapeutics May 1, 2015 Position: Chief development officer

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of California, San Francisco 1974 to 1979 Specialities: Philosophy, Chemistry

Skills

Pharmaceutical Industry • Clinical Development • Drug Development • Drug Discovery • Biotechnology • Fda • Leadership • Regulatory Affairs • Validation • Clinical Trials • Glp • Lifesciences • Cro • Gmp • Technology Transfer • Life Sciences • Analytical Chemistry • Mass Spectrometry • Lc Ms • Regulatory Submissions • Hplc • Cross Functional Team Leadership • Sop

Interests

Photography • Choral Singing • Walking My Dog • Woodworking

Industries

Pharmaceuticals

Resumes

Resumes

Craig Abolin Photo 1

Chief Development Officer

View page
Location:
Bellingham, WA
Industry:
Pharmaceuticals
Work:
Or-Genix Therapeutics
Chief Development Officer
Restorgenex Corporation Nov 2013 - Apr 2015
Vice President Pharmaceutical Sciences
Hygeia Therapeutics Nov 2007 - Nov 2013
Chief Strategy Officer
Canterbury Laboratories Mar 2012 - Nov 2013
Chief Strategy Officer
Sunovion Pharmaceuticals Inc. May 2000 - Jul 2007
Director Dm and Pk
Education:
University of California, San Francisco 1974 - 1979
Doctorates, Doctor of Philosophy, Philosophy, Chemistry West Virginia University 1972 - 1974
Masters West Virginia University 1966 - 1971
Bachelors, Pharmacy
Skills:
Pharmaceutical Industry
Clinical Development
Drug Development
Drug Discovery
Biotechnology
Fda
Leadership
Regulatory Affairs
Validation
Clinical Trials
Glp
Lifesciences
Cro
Gmp
Technology Transfer
Life Sciences
Analytical Chemistry
Mass Spectrometry
Lc Ms
Regulatory Submissions
Hplc
Cross Functional Team Leadership
Sop
Interests:
Photography
Choral Singing
Walking My Dog
Woodworking

Publications

Us Patents

Carbamate Stereoisomer

View page
US Patent:
8173829, May 8, 2012
Filed:
Mar 31, 2010
Appl. No.:
12/751563
Inventors:
Craig R. Abolin - Boylston MA, US
H. Scott Wilkinson - Westborough MA, US
Paul McGlynn - Northborough MA, US
William K. McVicar - Sudbury MA, US
Assignee:
Sunovion Pharmaceuticals Inc. - Marlborough MA
International Classification:
C07C 271/06
US Classification:
560 27, 514478, 514479
Abstract:
The compound of formula (I).

Acetamide Stereoisomer

View page
US Patent:
8501994, Aug 6, 2013
Filed:
Aug 22, 2008
Appl. No.:
12/196520
Inventors:
Craig R. Abolin - Boylston MA, US
H. Scott Wilkinson - Westborough MA, US
Paul McGlynn - Northborough MA, US
William K. McVicar - Sudbury MA, US
Assignee:
Sunovion Pharmaceuticals Inc. - Marlborough MA
International Classification:
C07C 233/05
A61K 31/16
US Classification:
564221, 564216, 564217, 564223, 514630
Abstract:
The compound of formula (I).

Carbamate Stereoisomer

View page
US Patent:
20090060917, Mar 5, 2009
Filed:
Aug 21, 2008
Appl. No.:
12/196071
Inventors:
Craig R. Abolin - Boylston MA, US
H. Scott Wilkinson - Westborough MA, US
Paul McGlynn - Northborough MA, US
William K. McVicar - Sudbury MA, US
Assignee:
Sepracor Inc. - Marlborough MA
International Classification:
A61K 39/395
A61K 31/56
A61K 31/4355
A61K 31/46
C07C 237/20
A61P 11/00
A61K 31/165
A61K 31/40
A61K 38/48
A61K 38/18
US Classification:
4241391, 514171, 514304, 514291, 514424, 424 9463, 514 12, 564165, 514620
Abstract:
The compound of formula (I)is a water-stable, long acting β-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.

Estrogen Receptor Beta Selective Ligands

View page
US Patent:
20200377546, Dec 3, 2020
Filed:
Aug 21, 2017
Appl. No.:
16/326525
Inventors:
- Worcester MA, US
Craig Abolin - Worcester MA, US
International Classification:
C07J 1/00
A61K 8/63
A61Q 7/00
Abstract:
An estrogen receptor β selective ligand can be a compound according to Structure 1:wherein m is 0, 1, or 2 and R is H, a Cto Calkyl group, vinyl, CF, CHCHF, CHCHF, or CHCF. A composition (e.g., pharmaceutical or cosmetic composition) can include an effective amount of a compound according to Structure 1 and a physiologically acceptable carrier, diluent, or excipient, formulated for topical administration. A method (e.g., therapeutic or cosmetic method) can include administering to a subject in need thereof an effective amount of a compound according to Structure 1 or a composition including Structure 1. Administration can be topical (e.g., to skin, scalp or mucosa).
Control profile
Craig R Abolin from Eastsound, WA, age ~76 Get Report